Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry

Journal of Virology
Yushun WanFang Li

Abstract

Antibody-dependent enhancement (ADE) of viral entry has been a major concern for epidemiology, vaccine development, and antibody-based drug therapy. However, the molecular mechanism behind ADE is still elusive. Coronavirus spike protein mediates viral entry into cells by first binding to a receptor on the host cell surface and then fusing viral and host membranes. In this study, we investigated how a neutralizing monoclonal antibody (MAb), which targets the receptor-binding domain (RBD) of Middle East respiratory syndrome (MERS) coronavirus spike, mediates viral entry using pseudovirus entry and biochemical assays. Our results showed that MAb binds to the virus surface spike, allowing it to undergo conformational changes and become prone to proteolytic activation. Meanwhile, MAb binds to cell surface IgG Fc receptor, guiding viral entry through canonical viral-receptor-dependent pathways. Our data suggest that the antibody/Fc-receptor complex functionally mimics viral receptor in mediating viral entry. Moreover, we characterized MAb dosages in viral-receptor-dependent, Fc-receptor-dependent, and both-receptors-dependent viral entry pathways, delineating guidelines on MAb usages in treating viral infections. Our study reveals a ...Continue Reading

References

Feb 13, 2001·Journal of Virology·A TakadaY Kawaoka
Apr 12, 2003·The New England Journal of Medicine·Thomas G KsiazekUNKNOWN SARS Working Group
Apr 25, 2003·Lancet·J S M PeirisUNKNOWN SARS study group
May 3, 2003·Viral Immunology·Sol M Cancel Tirado, Kyoung-Jin Yoon
Jun 14, 2003·Journal of Virology·Ayato TakadaYoshihiro Kawaoka
Nov 20, 2003·Reviews in Medical Virology·Ayato Takada, Yoshihiro Kawaoka
Apr 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yuxian HeShibo Jiang
Aug 24, 2005·Proceedings of the National Academy of Sciences of the United States of America·Shutoku MatsuyamaFumihiro Taguchi
Aug 30, 2005·Molecular & Cellular Proteomics : MCP·Mathias UhlénFredrik Pontén
May 23, 2006·Annual Review of Microbiology·Luis EnjuanesSonia Zuñiga
May 8, 2007·Emerging Infectious Diseases·Maria G GuzmanScott B Halstead
Jun 15, 2007·Nature Reviews. Microbiology·Stephen S WhiteheadBrian R Murphy
May 9, 2009·Biochemical and Biophysical Research Communications·Lanying DuShibo Jiang
May 12, 2009·Nature Reviews. Microbiology·Stanley Perlman, Jason Netland
May 8, 2010·Science·Wanwisa DejnirattisaiGavin Screaton
May 17, 2012·Viruses·Taylor Heald-Sargent, Tom Gallagher
Jul 21, 2012·Viruses·Sandrine BelouzardGary R Whittaker
Oct 19, 2012·The New England Journal of Medicine·Ali M ZakiRon A M Fouchier
Jul 30, 2014·Biochemical and Biophysical Research Communications·Sheng-Fan WangJason C Huang
Aug 13, 2014·Proceedings of the National Academy of Sciences of the United States of America·Yang YangFang Li
Oct 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Jean Kaoru Millet, Gary R Whittaker
Jan 24, 2015·Science·Mathias UhlénFredrik Pontén
Mar 20, 2015·Journal of Virology·Chang LiuFang Li
Mar 5, 2016·Nature·Robert N KirchdoerferAndrew B Ward

❮ Previous
Next ❯

Citations

Mar 14, 2020·The Journal of Clinical Investigation·Arturo Casadevall, Liise-Anne Pirofski
Apr 2, 2020·The Journal of Infectious Diseases·Nir EyalPeter G Smith
Apr 8, 2020·The Journal of Clinical Investigation·Evan M BlochAaron Ar Tobian
Apr 11, 2020·The American Journal of Tropical Medicine and Hygiene·Scott B Halstead
May 22, 2020·Journal of Medical Virology·Kamal Kant SahuJonathan M Gerber
Jun 20, 2020·Journal of Cellular Physiology·Mahnaz GhaebiMajid Ahmadi
Jul 3, 2020·Journal of Clinical Medicine·Francesco CappelloAlberto Jl Macario
Jul 15, 2020·Human Vaccines & Immunotherapeutics·Abdolkarim Sheikhi, Mohammad Hojjat-Farsangi
May 30, 2020·International Journal of Clinical Practice·Richard A Stein, Lauren M Young
Jun 28, 2020·Journal of Virology·John P Moore, P J Klasse
Jul 15, 2020·Critical Reviews in Clinical Laboratory Sciences·Bingliang Fang, Qing H Meng
Jul 8, 2020·The Journal of Clinical Investigation·Arturo CasadevallLiise-Anne Pirofski
Jul 15, 2020·Angewandte Chemie·Tingting YeBruno G De Geest
Sep 24, 2020·Journal of Racial and Ethnic Health Disparities·Nicole PhillipsHarlan P Jones
Aug 18, 2020·Transboundary and Emerging Diseases·Guangzhi ZhangShangjin Cui
Apr 18, 2020·Immunity & Ageing : I & a·Graham Pawelec, Nan-Ping Weng
Jul 13, 2020·Journal of Neurology·Marcel S WooManuel A Friese
Jun 24, 2020·Biochemistry. Biokhimii︠a︡·O P Zhirnov
Jun 24, 2020·Frontiers in Immunology·Scott B Halstead, Ramesh Akkina
Jul 31, 2020·Virology Journal·Yicheng YangWei Zhao
Jul 22, 2020·Critical Care : the Official Journal of the Critical Care Forum·Manu Shankar-HariUNKNOWN United Kingdom SARS-CoV-2 Convalescent Plasma Evaluation (SCoPE) Consortium
Sep 24, 2020·Human Vaccines & Immunotherapeutics·Ankur GuptaShailendra K Saxena
Aug 23, 2020·Antioxidants·Paolo Bellavite, Alberto Donzelli
Apr 24, 2020·The Journal of Headache and Pain·Paolo Martelletti
Apr 23, 2020·Indian Journal of Ophthalmology·Rohit ShettySwaminathan Sethu
May 8, 2020·Biomedicines·Kenneth Lundstrom
Jun 12, 2020·The Journal of Clinical Investigation·Michael J JoynerArturo Casadevall
Jul 1, 2020·Turkish Journal of Biology = Türk Biyoloji Dergisi·Bertan Koray BalcioĞluAylin Özdemİr Bahadir
Jul 14, 2020·Frontiers in Immunology·Abdullah M IzmirlyElias K Haddad
Jun 9, 2020·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Henning UlrichAttila Tárnok
Jul 29, 2020·Frontiers in Immunology·Amélie GuihotVincent Vieillard
Aug 2, 2020·Nature Structural & Molecular Biology·Xiaoli XiongJohn A G Briggs
Oct 6, 2020·Frontiers in Immunology·Maria TrovatoPiergiuseppe De Berardinis
Aug 7, 2020·Human Vaccines & Immunotherapeutics·Sayeh EzzikouriKyoko Tsukiyama-Kohara
Sep 12, 2020·Nature Reviews. Microbiology·Emmanuel MargolinEdward P Rybicki
Sep 26, 2020·Frontiers in Immunology·Sana O AlturkiElias K Haddad
May 22, 2020·Therapeutic Advances in Respiratory Disease·Muhammad Hamdan GulAhmad Khan
Jul 3, 2020·Frontiers in Immunology·Luis F García
Aug 25, 2020·SN Comprehensive Clinical Medicine·Ramtin PourahmadNima Rezaei

❮ Previous
Next ❯

Datasets Mentioned

BETA
AFS88936.1
AFR58742

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
ELISA
flow cytometry
fluorescence-activated cell sorting
electron microscopy
gel filtration
transfection
PCR

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antibody-Dependent Enhancement

Antibody-dependent enhancement of viral infection is the entry of virus into host cells mediated by antiviral antibodies interacting with Fc or complement receptors. This has been most extensively observed with the dengue virus. Find the latest research on antibody-dependent enhancement here.